603439 Stock Overview
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Guizhou Sanli Pharmaceutical Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥11.83 |
52 Week High | CN¥20.34 |
52 Week Low | CN¥11.19 |
Beta | 0.71 |
11 Month Change | -7.22% |
3 Month Change | -25.27% |
1 Year Change | -25.92% |
33 Year Change | -7.72% |
5 Year Change | n/a |
Change since IPO | 11.81% |
Recent News & Updates
Recent updates
Is Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Trading At A 20% Discount?
Aug 03Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Intrinsic Value Is Potentially 73% Above Its Share Price
Apr 23Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly
Mar 25Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 06Shareholder Returns
603439 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 1.6% | 1.0% | -2.6% |
1Y | -25.9% | -12.0% | -20.6% |
Return vs Industry: 603439 underperformed the CN Pharmaceuticals industry which returned -12% over the past year.
Return vs Market: 603439 underperformed the CN Market which returned -20.6% over the past year.
Price Volatility
603439 volatility | |
---|---|
603439 Average Weekly Movement | 5.1% |
Pharmaceuticals Industry Average Movement | 5.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 603439's share price has been volatile over the past 3 months.
Volatility Over Time: 603439's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 2,282 | Hai Zhang | www.gz-sanli.com |
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine.
Guizhou Sanli Pharmaceutical Co.,Ltd Fundamentals Summary
603439 fundamental statistics | |
---|---|
Market cap | CN¥4.83b |
Earnings (TTM) | CN¥293.82m |
Revenue (TTM) | CN¥1.71b |
16.4x
P/E Ratio2.8x
P/S RatioIs 603439 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603439 income statement (TTM) | |
---|---|
Revenue | CN¥1.71b |
Cost of Revenue | CN¥470.35m |
Gross Profit | CN¥1.24b |
Other Expenses | CN¥943.85m |
Earnings | CN¥293.82m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
Earnings per share (EPS) | 0.72 |
Gross Margin | 72.46% |
Net Profit Margin | 17.20% |
Debt/Equity Ratio | 28.4% |
How did 603439 perform over the long term?
See historical performance and comparison